Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol

• Robert J Klaassen,
• Kristin A Shimano,
• Rachael F Grace,
• Jenny M Despotovic,
• Ellis J Neufeld,
• Carolyn M Bennett,
• Clement Ma,
• Wendy B London,
• Cindy Neunert

Affiliations

Robert J Klaassen

Children`s Hospital of Eastern Ontario, Ottawa, Ontario, Canada

Kristin A Shimano

UCSF Benioff Children`s Hospital, San Francisco, California, USA

Rachael F Grace

Dana-Farber/Boston Children`s Cancer and Blood Disorders Center, Boston, Massachusetts, USA

Jenny M Despotovic

Texas Children`s Hospital, Houston, Texas, USA

Ellis J Neufeld

St. Jude Children’s Research Hospital, Memphis, Tennessee, USA

Carolyn M Bennett

Pediatrics, Emory University, Atlanta, Georgia, USA

Clement Ma

Dana-Farber/Boston Children`s Cancer and Blood Disorders Center, Boston, Massachusetts, USA

Wendy B London

Dana-Farber/Boston Children`s Cancer and Blood Disorders Center, Boston, Massachusetts, USA

Cindy Neunert

Pediatrics, Columbia University Medical School, New York, New York, USA